| Literature DB >> 21151003 |
Christopher J van der Gast1, Alan W Walker, Franziska A Stressmann, Geraint B Rogers, Paul Scott, Thomas W Daniels, Mary P Carroll, Julian Parkhill, Kenneth D Bruce.
Abstract
Cystic fibrosis (CF) patients suffer from chronic bacterial lung infections that lead to death in the majority of cases. The need to maintain lung function in these patients means that characterising these infections is vital. Increasingly, culture-independent analyses are expanding the number of bacterial species associated with CF respiratory samples; however, the potential significance of these species is not known. Here, we applied ecological statistical tools to such culture-independent data, in a novel manner, to partition taxa within the metacommunity into core and satellite species. Sputa and clinical data were obtained from 14 clinically stable adult CF patients. Fourteen rRNA gene libraries were constructed with 35 genera and 82 taxa, identified in 2139 bacterial clones. Shannon-Wiener and taxa-richness analyses confirmed no undersampling of bacterial diversity. By decomposing the distribution using the ratio of variance to the mean taxon abundance, we partitioned objectively the species abundance distribution into core and satellite species. The satellite group comprised 67 bacterial taxa from 33 genera and the core group, 15 taxa from 7 genera (including Pseudomonas (1 taxon), Streptococcus (2), Neisseria (2), Catonella (1), Porphyromonas (1), Prevotella (5) and Veillonella (3)], the last four being anaerobes). The core group was dominated by Pseudomonas aeruginosa. Other recognised CF pathogens were rare. Mantel and partial Mantel tests assessed which clinical factors influenced the composition observed. CF transmembrane conductance regulator genotype and antibiotic treatment correlated with all core taxa. Lung function correlated with richness. The clinical significance of these core and satellite species findings in the CF lung is discussed. GenBank accession numbers: FM995625–FM997761Entities:
Mesh:
Substances:
Year: 2010 PMID: 21151003 PMCID: PMC3105771 DOI: 10.1038/ismej.2010.175
Source DB: PubMed Journal: ISME J ISSN: 1751-7362 Impact factor: 10.302
Clinical characteristics for individual patients
| 1 | 30 | M | ΔF508/NK | 2.51 | 29.0 | 37.4 | N | N | N | N | N | N | Y | N | N | Y |
| 2 | 45 | F | ΔF508/NK | 1.30 | 18.2 | 36.5 | Y | Y | Y | N | N | N | N | N | N | Y |
| 3 | 47 | M | ΔF508/NK | 1.23 | 19.9 | 35.9 | Y | Y | Y | N | N | N | Y | N | N | Y |
| 4 | 30 | F | ΔF508/711+3A7G | 1.30 | 27.1 | 37.3 | N | Y | N | N | N | N | Y | N | N | Y |
| 5 | 22 | F | ΔF508/ΔF508 | 1.23 | 18.0 | 37.8 | N | Y | Y | N | N | Y | Y | N | N | Y |
| 6 | 55 | M | ΔF508/G58E | 1.59 | 23.9 | 36.5 | N | Y | Y | N | N | N | Y | N | N | Y |
| 7 | 21 | F | ΔF508/ΔF508 | 1.68 | 20.3 | 36.5 | N | Y | Y | N | N | N | Y | N | N | Y |
| 8 | 40 | M | ΔF508/ΔF508 | 1.91 | 19.4 | 37.0 | Y | Y | Y | N | N | N | N | N | Y | Y |
| 9 | 22 | M | ΔF508/ΔF508 | 0.73 | 18.4 | 36.2 | Y | Y | Y | N | N | N | Y | Y | N | Y |
| 10 | 17 | F | ΔF508/ΔF508 | 2.86 | 22.5 | 37.3 | N | Y | N | N | Y | N | Y | N | N | Y |
| 11 | 24 | F | ΔF508/G542X | 2.17 | 21.0 | 36.9 | N | Y | Y | N | N | N | Y | N | N | Y |
| 12 | 20 | M | ΔF508/ΔF508 | 1.19 | 20.4 | 36.9 | N | Y | N | Y | N | N | N | N | N | N |
| 13 | 20 | M | ΔF508/ΔF508 | 2.10 | 28.5 | 37.5 | N | N | N | N | Y | Y | Y | N | Y | Y |
| 14 | 23 | M | ΔF508/ΔF508 | 3.21 | 21.1 | 35.9 | Y | N | Y | N | N | N | N | N | N | Y |
Abbreviations: BMI, body mass index (kg m−2); CFTR, cystic fibrosis transmembrane conductance regulator; FEV1, forced expiratory volume (litres) in 1 s; N, no; NK, genotype not known; Y, yes.
Internal body temperature (°C) at the time of sampling.
Antibiotics were delivered by a nebuliser.
Bacterial taxa sampled from the lungs of the 14 cystic fibrosis patients
| Actinobacteria | Actinomycetaceae | S, Ae, O | |
| S, Ae, O | |||
| S, Ae, O | |||
| S, Ae, O | |||
| Micrococcineae | S, Ae, O | ||
| S, Ae, O | |||
| Bacteroides | Bacteroidaceae | S, An | |
| S, An | |||
| S, An | |||
| S, An | |||
| S, An | |||
| Porphyromonadaceae | C, An, O | ||
| S, An, O | |||
| Prevotellaceae | S, An, O | ||
| C, An, O | |||
| S, An | |||
| S, An, O | |||
| C, An, O | |||
| S, An, O | |||
| S, An, O | |||
| S, An | |||
| C, An, O | |||
| C, An, O | |||
| C, An, O | |||
| Rikenellaceae | S, An, O | ||
| Flavobacteria | Flavobacteriaceae | S, Ae, O | |
| S, Ae, O | |||
| S, Ae, O | |||
| S, Ae, O | |||
| Bacilli | Staphylococcaceae | S, Ae, O | |
| S, Ae | |||
| Aerococcaceae | S, Ae, O | ||
| Carnobacteriaceae | S, Ae, O | ||
| S, Ae, O | |||
| Streptococcaceae | S, Ae, O | ||
| S, Ae, O | |||
| S, Ae, O | |||
| C, Ae, O | |||
| S, Ae, O | |||
| C, Ae, O | |||
| S, Ae, O | |||
| S, Ae | |||
| S, Ae, O | |||
| S, Ae, O | |||
| S, Ae, O | |||
| Clostridia | Clostridiaceae | S, Ae | |
| Eubacteriaceae | S, Ae, O | ||
| Lachnospiraceae | C, An, O | ||
| S, An | |||
| S, An | |||
| S, An | |||
| S, An | |||
| Butyrate-producer SR1/1 (97%) | S, An | ||
| Veillonellaceae | C, An, O | ||
| C, An, O | |||
| C, An, O | |||
| S, An, O | |||
| S, An, O | |||
| S, An, O | |||
| S, An, O | |||
| Fusobacteria | Fusobacteriaceae | S, An, O | |
| S, An, O | |||
| S, An, O | |||
| Betaproteobacteria | Alcaligenaceae | S, Ae | |
| Neisseriales | S, Ae, O | ||
| C, Ae, O | |||
| S, Ae, O | |||
| C, Ae, O | |||
| S, Ae, O | |||
| S, Ae, O | |||
| S, Ae, O | |||
| Epsilonproteobacteria | Campylobacteraceae | S, Ae, O | |
| S, Ae, O | |||
| Gammaproteobacteria | Altermonadaceae | S, Ae | |
| Pastuerellaceae | S, Ae, O | ||
| S, Ae, O | |||
| S, Ae | |||
| S, Ae | |||
| S, An | |||
| Moraxellaceae | S, Ae | ||
| Pseudomonadaceae | C, Ae | ||
| Xanthomonadaceae | S, Ae |
Abbreviations: C, core group taxon; S, satellite group; Ae, aerobe; An, anaerobe; O, taxa associated with the oral microbiota.
Figure 1Distribution and dispersal of bacterial taxa across patients. (a) The number of patients for whom each bacterial taxon was observed, plotted against the mean abundance (log10 scale) across all patients (r2=0.44; F1,80=62.2; P<0.0001). (b) Random and non-random dispersal through space visualised by decomposing the overall distribution using an index of dispersion based on the ratio of variance to the mean abundance for each bacterial taxon from the 14 patients sampled. The line depicts the 2.5% confidence limit for the χ2 distribution. The 97.5% confidence limit was not plotted, as no taxon fell below that line.
Figure 2The abundance distributions for the bacterial metacommunity for (a) all taxa, (b) core taxa best predicted by the log-normal model (χ2(4)=2.71; P=0.607) and (c) satellite taxa best predicted by the log-series model (χ2(4)=4.61; P=0.330). The frequency of each log2 abundance class predicted by the log-normal and -series models is shown as a dot.
Figure 3The richness and abundance of (a) aerobic and anaerobic bacteria and (b) oral microbiota within the whole metacommunity, the core group and the satellite group. Also given are the actual values of taxa richness and abundance (number of clones). Shaded areas represent percentage abundance of Pseudomonas aeruginosa within the whole metacommunity and the core group of bacterial taxa.
Figure 4Dendrograms of bacterial community composition in the 14 patients for (a) all taxa, (b) the core and (c) satellite taxa groups. Patient taxa profiles were compared using the Bray–Curtis quantitative index of similarity and average linkage clustering.
Mantel and partial Mantel test summary statistics
| r(SA) | P | r(SG) | P | r(SA.G) | P | r(SG.A) | P | |
|---|---|---|---|---|---|---|---|---|
| Whole community | 0.516 | 0.0001* | −0.294 | 0.003* | 0.509 | 0.0001* | −0.278 | 0.008* |
| Core group | 0.504 | 0.0001* | −0.350 | 0.001* | 0.499 | 0.0001* | −0.343 | 0.002* |
| Satellite group | −0.255 | 0.994 | 0.077 | 0.763 | −0.249 | 0.992 | 0.050 | 0.687 |
The partial Mantel statistic r(SA.G) estimates the correlation between S (community similarity) and A (similarity in antibiotic treatments), while controlling for the effect of G (differences in CF genotype). Conversely, r(SG.A) estimates the correlation between S and G, while controlling for A. Mantel test statistics to examine the correlation between S and A or G, respectively, are given. The P-values have been calculated using the distribution of the partial Mantel or Mantel test statistic estimated from 9999 permutations. Asterisks denote those relationships that were significant at the P<0.05 level.
Figure 5The relationships between bacterial taxa richness and lung function (FEV1 in litres) for (a) the whole metacommunity, (b) the core group and (c) the satellite group. In each case linear regression lines have been fitted. For the whole metacommunity, r2=0.43, F1,12=9.2, P<0.01; core group, r2=0.40, F1,12=7.82, P<0.02; and satellite group, r2=0.42, F1,12=8.67, P<0.01.